207 related articles for article (PubMed ID: 35189442)
41. Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents.
Jameel E; Meena P; Maqbool M; Kumar J; Ahmed W; Mumtazuddin S; Tiwari M; Hoda N; Jayaram B
Eur J Med Chem; 2017 Aug; 136():36-51. PubMed ID: 28478343
[TBL] [Abstract][Full Text] [Related]
42. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J
Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907
[TBL] [Abstract][Full Text] [Related]
43. In silico, theoretical biointerface analysis and in vitro kinetic analysis of amine compounds interaction with acetylcholinesterase and butyrylcholinesterase.
Kandasamy S; Loganathan C; Sakayanathan P; Karthikeyan S; Stephen AD; Marimuthu DK; Ravichandran S; Sivalingam V; Thayumanavan P
Int J Biol Macromol; 2021 Aug; 185():750-760. PubMed ID: 34216669
[TBL] [Abstract][Full Text] [Related]
44. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
[TBL] [Abstract][Full Text] [Related]
45. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N
Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578
[TBL] [Abstract][Full Text] [Related]
46. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors.
Parlar S; Bayraktar G; Tarikogullari AH; Alptüzün V; Erciyas E
Chem Pharm Bull (Tokyo); 2016; 64(9):1281-7. PubMed ID: 27581632
[TBL] [Abstract][Full Text] [Related]
47. Structure-activity study of fluorine or chlorine-substituted cinnamic acid derivatives with tertiary amine side chain in acetylcholinesterase and butyrylcholinesterase inhibition.
Gao XH; Tang JJ; Liu HR; Liu LB; Liu YZ
Drug Dev Res; 2019 Jun; 80(4):438-445. PubMed ID: 30680760
[TBL] [Abstract][Full Text] [Related]
48. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
[TBL] [Abstract][Full Text] [Related]
49. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
[TBL] [Abstract][Full Text] [Related]
50. Molecular-docking-guided design and synthesis of new IAA-tacrine hybrids as multifunctional AChE/BChE inhibitors.
Cheng ZQ; Zhu KK; Zhang J; Song JL; Muehlmann LA; Jiang CS; Liu CL; Zhang H
Bioorg Chem; 2019 Mar; 83():277-288. PubMed ID: 30391700
[TBL] [Abstract][Full Text] [Related]
51. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
[TBL] [Abstract][Full Text] [Related]
52. Analogues of 2'-hydroxychalcone with modified C4-substituents as the inhibitors against human acetylcholinesterase.
Sukumaran SD; Nasir SB; Tee JT; Buckle MJC; Othman R; Rahman NA; Lee VS; Bukhari SNA; Chee CF
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):130-137. PubMed ID: 33243025
[TBL] [Abstract][Full Text] [Related]
53. Design, Synthesis, and Biological Evaluation of Dual-Target Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 9A (PDE9A) for the Treatment of Alzheimer's Disease.
Hu J; Huang YD; Pan T; Zhang T; Su T; Li X; Luo HB; Huang L
ACS Chem Neurosci; 2019 Jan; 10(1):537-551. PubMed ID: 30252439
[TBL] [Abstract][Full Text] [Related]
54. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
[TBL] [Abstract][Full Text] [Related]
55. Interest of novel N-alkylpyridinium-indolizine hybrids in the field of Alzheimer's disease: Synthesis, characterization and evaluation of antioxidant activity, cholinesterase inhibition, and amyloid fibrillation interference.
Baussanne I; Firstova O; Dediu AB; Larosa C; Furdui B; Ghinea IO; Thomas A; Chierici S; Dinica R; Demeunynck M
Bioorg Chem; 2021 Nov; 116():105390. PubMed ID: 34670332
[TBL] [Abstract][Full Text] [Related]
56. Design, synthesis, in silico and biological evaluations of novel polysubstituted pyrroles as selective acetylcholinesterase inhibitors against Alzheimer's disease.
Pourtaher H; Hasaninejad A; Iraji A
Sci Rep; 2022 Sep; 12(1):15236. PubMed ID: 36075926
[TBL] [Abstract][Full Text] [Related]
57. Design, Synthesis, Molecular Docking, and Cholinesterase Inhibitory Potential of Phthalimide-Dithiocarbamate Hybrids as New Agents for Treatment of Alzheimer's Disease.
Asadi M; Ebrahimi M; Mohammadi-Khanaposhtani M; Azizian H; Sepehri S; Nadri H; Biglar M; Amanlou M; Larijani B; Mirzazadeh R; Edraki N; Mahdavi M
Chem Biodivers; 2019 Nov; 16(11):e1900370. PubMed ID: 31523926
[TBL] [Abstract][Full Text] [Related]
58. Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease.
Singh YP; Shankar G; Jahan S; Singh G; Kumar N; Barik A; Upadhyay P; Singh L; Kamble K; Singh GK; Tiwari S; Garg P; Gupta S; Modi G
Bioorg Med Chem; 2021 Sep; 46():116385. PubMed ID: 34481338
[TBL] [Abstract][Full Text] [Related]
59. Synthesis, characterisation, DNA binding, acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) activities and molecular docking studies of metal(II) complexes with 1,10-phenanthroline scaffold.
Gladis EHE; Nagashri K; Anisha M; Joseph J
J Biomol Struct Dyn; 2023 Jul; 41(11):5067-5085. PubMed ID: 35699274
[TBL] [Abstract][Full Text] [Related]
60. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK
Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
